Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

siRNA Nanoparticle Suppresses Drug‐Resistant Gene and Prolongs Survival in an Orthotopic Glioblastoma Xenograft Mouse Model

Advanced Functional Materials(2020)10.1002/adfm.202007166Source: DataRank Database

siRNA Nanoparticle Suppresses Drug‐Resistant Gene and Prolongs Survival in an Orthotopic Glioblastoma Xenograft Mouse Model is a research paper published in Advanced Functional Materials (2020). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.49)OA: greenTopics (23)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Forrest M. Kievit ORCID,Peter A. Chiarelli ORCID,Zachary R. Stephen ORCID,Guanyou Lin ORCID,John R. Silber ORCID

Live enrichment

PubMed:33708035 PMC:PMC7942690 OpenAlex:https://openalex.org/W3096041557

National Institutes of Health

Grant: NIH/NCI R01CA161953

National Institutes of Health

Grant: NIH/NIBIB R01EB026890

National Science Foundation

Grant: NNCI‐1542101

NCI NIH HHS

Grant: R01 CA161953

NCI NIH HHS

Grant: T32 CA138312

NIBIB NIH HHS

Grant: R01 EB026890

National Institutes of Health

Grant: 5T32CA138312-03

Nanotechnology and Physical Science Training Program in Cancer Research

National Institutes of Health

Grant: 5R01CA161953-03

Multifunctional nanoparticles to improve treatment of human glioblastoma

National Institutes of Health

Grant: 5R01EB026890-03

Iron oxide nanotheranostics for breast cancer

National Science Foundation

Grant: 1542101

NNCI: Northwest Nanotechnology Infrastructure (NWNI)

University of Washington

FWCI

1.49

Citation Percentile

0.8%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7942690

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942690

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7942690

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202007166

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/adfm.202007166

Fields of Study

RNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesNanoparticle-Based Drug DeliveryMedicineMaterials Science0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

GlioblastomaMaterials scienceCancer researchDrugNanoparticlePharmacologyNanotechnologyMedicineDrug resistanceBrain tumorTreatment ResistanceSirna DeliveryO6-methylguanine-dna MethyltransferaseNano Drug CarriersGbm Stem Cell

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma

10.6084/m9.figshare.25853053.v1figshare

Additional file 1 of Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma

10.6084/m9.figshare.25853053figshare

Additional file 1 of Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma

10.6084/m9.figshare.26602396.v1figshare

Additional file 1 of Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma

10.6084/m9.figshare.26602396figshare